HMGXB4: A Drug Target / Disease Biomarker (G10042)

Target Name: HMGXB4

NCBI ID: G10042

HMGXB4

HMGXB4: A Drug Target / Disease Biomarker

HMGXB4, also known as 2-oxoglutarate dehydrogenase (2-OGDH), is a protein that is expressed in various tissues throughout the body. It is involved in the metabolism of 2-oxoglutarate, a metabolite that is produced by the liver and other tissues. 2-OGDH is a key enzyme in the citric acid cycle, which is a process that occurs in the liver and other tissues to produce energy.

HMGXB4 is a protein that is expressed in the liver, and it is involved in the metabolism of 2-oxoglutarate. 2-OGDH is a key enzyme in the citric acid cycle, which is a process that occurs in the liver and other tissues to produce energy.

One of the key functions of HMGXB4 is its role in the production of 2-oxoglutarate, which is a metabolite that is produced by the liver and other tissues. 2-OGDH is the enzyme that converts 2-oxoglutarate to 2-pyruvate, which is a key step in the citric acid cycle.

In addition to its role in the production of 2-oxoglutarate, HMGXB4 is also involved in the regulation of the citric acid cycle. It helps to maintain the proper balance of citric acid cycle intermediates, which are essential for the production of energy in the body.

HMGXB4 is also involved in the regulation of cellular processes. It helps to maintain the proper levels of various cellular organelles, such as mitochondria and endoplasmic reticulum, which are important for the proper functioning of cells.

HMGXB4 is a protein that is expressed in various tissues throughout the body. It is involved in the metabolism of 2-oxoglutarate, which is a metabolite that is produced by the liver and other tissues. 2-OGDH is a key enzyme in the citric acid cycle, which is a process that occurs in the liver and other tissues to produce energy. It is also involved in the regulation of the citric acid cycle and in the regulation of cellular processes.

Protein Name: HMG-box Containing 4

Functions: Negatively regulates Wnt/beta-catenin signaling during development

The "HMGXB4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HMGXB4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets